Thus, the occurrence of PR3-ANCAs in up to 54% of PSC patients and their predictive value for disease severity ushered in a new era in the serological diagnosis of PSC as an autoimmune liver disorder [11,14]. Here, PRTN3 is linked to pancreatic serous cystadenoma.